Development Document for Proposed Effluent Limitations Guidelines, New Source Performance Standards and Pretreatment Standards for the Pharmaceutical Manufacturing Point Source Category. (See EPA 440-1-82-084).
This document presents the findings of a study of the Pharmaceutical Manufacturing Point Source Category for the purpose of developing effluent limitations guidelines for existing and new point sources and to establish pretreatment standards for existing and new dischargers to publicly owned treatment works to implement Sections 301, 304, 306, 307, 308 and 501 of the Clean Water Act (the Federal Water Pollution Control Act Amendments of 1972, 33 USC 125) et. seq., as amended by the Clean Water Act of 1977, P.L. 95-217 (the "Act")).
|Office of Water|
|Effluent Guidelines Division|
|Office of Water Regulations and Standards|
|Hund, Frank H.; Lent, Daniel S.; Vitalis, Joseph S.|
|Background Cost-Related Document|